Lupin shares
Nifty, Bank Nifty outlook: Nifty to trade in 15,600-15,900 range, Bank Nifty may top 37,000; Infosys in focus
The chart pattern suggests that if Nifty crosses and sustains above 15950 level it would witness buying which would lead the index towards 16100-16300 levels
Buy HDFC, Axis Bank, Lupin, M&M stocks to pocket gains; Nifty support at 15,700-15,750
On Wednesday 15900/15930 (53000/53100) would be major hurdles and support would be at 15730/52500 and 15700/52400 levels.
राकेश झुनझुनवाला का पसंदीदा फार्मा शेयर 52 हफ्ते की नई ऊंचाई पर, जानें क्या है वजह?
पिछले साल जुलाई में ल्युपिन के शेयर 828 रुपये तक गिर गए थे. यह इस शेयर के 52 सप्ताह की सबसे ज
Rakesh Jhunjhunwala-owned drug stock hits new 52-week high; charts show it may rally up to 20% more
Rakesh Jhunjhunwala-owned Lupin share price surged as high as 4.7 per cent to Rs 1,266.35 apiece in intraday deals on BSE, in an otherwise weak market.
Nifty may trade in 14,400-15,000 range this week, Bank Nifty below 20, 50, 100 day SMAs; Wipro, Cipla in focus
The chart pattern suggests that if Bank Nifty crosses and sustains above 33000 level it would witness buying which would lead the index towards 33500-34500 levels.
L&T, Cipla, Lupin, Dr Reddy’s, Vedanta, GAIL, Tata Power, Reliance Infrastructure stocks in focus
Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening for BSE Sensex and Nifty 50
Lupin reports 18 pc increase in Q4 net profit at Rs 460 cr; FY21 profit at Rs 1,216 cr
The company said its board has recommended a dividend of Rs 6.5 per equity share of the face value of Rs 2 each aggregating to Rs 295 crore.
Sanjiv Bhasin’s stock picks for next 5 months; sees Nifty at 15,000, Bank Nifty near 34,250 by May-end
Indian share market benchmarks BSE Sensex and Nifty 50 have been witnessing volatility amid the second COVID-19 wave.
Nifty to hit 17,200 by Dec 2021; ICICI Bank, Bharti Airtel, others may rally up to 36% as earnings recover
February 2021 proved to be a roller coaster ride for the Nifty 50 index, where the first trading day of the month saw a 5 per cent rise in the index, while the last day witnessed a correction of 4 per cent.
राकेश झुनझुनवाला के पसंदीदा शेयरों ने कोरोना का जमकर किया मुकाबला, मार्च के बाद 207% तक दिए रिटर्न
Rakesh Jhunjhunwala Favorite Stocks: राकेश झुनझुनवाला के पसंद के शेयरों ने मार्च की गिरावट के बाद से कैसा प्र
राकेश झुनझुनवाला ने एग्रोटेक फूड, ल्यूपिन में बढ़ाई हिस्सेदारी; पोर्टफोलियो में Tata Motors भी शामिल
3 pharma stocks set to gain 25% as cardiac remains dominant therapy in Indian pharma market
According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.
Stocks in focus: Lupin, TVS Motor, United Spirits, Adani Power, among others to remain in action
Federal Bank, CEAT, Heidelbergcement India, Lupin, TVS Motor, IIFL Finance, Muthoot Capital Services, Radico Khaitan, Rain Industries, Tata Steel Long Products and Wendt (India) are among 24 companies are scheduled to announc
Lupin shares tank 8% despite 48% rise in Q4 net profit, here is why
Lupin Limited shares plunged nearly 8 per cent in early trade on Friday despite the pharma major reported 47.54 per cent rise in its consolidated net profit figures at Rs 807.08 crore for the quarter ended March 31, 2016
Lupin shares tank over 10% intraday in today’s trade, here is why
In the past one year, share price of Lupin tanked 25.21 per cent to Rs 1495.10 till March 28, whereas the benchmark index Nifty Pharma index slipped 13.73 per cent during the same period.
Lupin shares surge over 5% as USFDA approves key anti-cholesterol drug
Lupin shares soared around 8 per cent in the morning trade on Thursday on reports that the company get approval for key anti-cholesterol drug from USFDA.
